Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...
Read Full NewsA trio of neurology experts discussed the clinical application of the 2025 updated multiple sclerosis diagnostic criteria, including imaging and biomarker tools, to support patient care.
A look back at clinician-led features from 2025 that examine the questions, data, and decisions shaping neurologic care.
Q1 2026 Preview: 5 FDA Decisions to Watch in Specialty Care
1.
Scholastic performance is a key concern for young cancer patients, study finds
2.
Acupuncture may alleviate nocturia in men treated for prostate cancer
3.
AI catches one-third of interval breast cancers missed at screening
4.
Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.
5.
Obesity-associated cancers tripled nationwide over past two decades
1.
CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma: A Comprehensive Review
2.
Understanding the Importance of CA125: A Comprehensive Guide
3.
Managing Acute Respiratory Failure in Hematological Malignancies
4.
What Is Gastrinoma? Understanding This Rare Tumor and Its Treatment Options
5.
Hope for a Cure: Exploring New Treatments for Sickle Cell Anemia
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
3.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge